All In Biotech

Drug Trial Radar · NCT05827978

Study of mRNA-1010 Seasonal Influenza Vaccine in Adults

A Phase 3, Randomized, Stratified, Observer-Blind, Active-Controlled Study to Evaluate the Immunogenicity, Reactogenicity and Safety of mRNA-1010 Seasonal Influenza Vaccine in Adults 18 Years and Older

Last checked: Nov 19, 2026Latest source record: Jul 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 8,411 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

8,411

Actual

Start

Apr 17, 2023

Primary completion

Jun 24, 2024

Study completion Jun 24, 2024

Sponsor

Lead sponsor
ModernaTX, Inc.Moderna (MRNA)
Sponsor type
Industry
First posted
Apr 25, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study includes 3 parts: Parts A, B, and C. The purpose of this study is to evaluate the immunogenicity and safety of mRNA-1010 seasonal influenza vaccine in adults.

Conditions

  • Seasonal Influenza

Interventions

  • mRNA-1010Biological

    Sterile liquid for injection

  • Licensed Quadrivalent Inactivated Seasonal Influenza VaccineBiological

    Sterile suspension for injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Geometric Mean Titer (GMT) of Anti-Hemagglutinin (HA) Antibody Levels as Measured by Hemagglutination Inhibition (HAI)Time frame: Day 29
  2. Percentage of Participants Reaching Seroconversion, as Measured by HAITime frame: Day 29
  3. Number of Participants With Solicited Local and Systemic Adverse Reactions (ARs)Time frame: Up to 7 days after study injection
  4. Number of Participants With Unsolicited Adverse Events (AEs)Time frame: Up to 28 days after study injection
  5. Number of Participants With Medically Attended Adverse Events (MAAEs), Adverse Events of Special Interest (AESIs), SAEs, and AEs Leading to DiscontinuationTime frame: Day 1 through Day 181

Locations

103 sites in 1 country. Site status is shown where the registry gives one.

  • Pinnacle Research Group

    Anniston, Alabama

  • North Alabama Research Center LLC

    Athens, Alabama

  • Cullman Research Center

    Cullman, Alabama

  • Medical Affiliated Research Center Inc

    Huntsville, Alabama

  • Desert Clinical Research - CCT

    Mesa, Arizona

  • Foothills Research Center - CCT

    Phoenix, Arizona

  • Fiel Family & Sports Medicine - PC - CCT

    Tempe, Arizona

  • Noble Clinical Research

    Tucson, Arizona

  • Baptist Health Center for Clinical Research

    Little Rock, Arkansas

  • Velocity Clinical Research, Banning

    Banning, California

  • Synexus Clinical Research US, Inc. - Cerritos

    Cerritos, California

  • Marvel Clinical Research 002, LLC

    Huntington Beach, California

  • Velocity Clinical Research

    La Mesa, California

  • Pasadena Clinical Trials

    Pasadena, California

  • Artemis Institute For Clinical Research LLC - Riverside - Headlands

    Riverside, California

  • Peninsula Research Associates - CRN

    Rolling Hills Estates, California

  • Optimal Research, LLC

    San Diego, California

  • Acclaim Clinical Research

    San Diego, California

  • Optimus Medical Group

    San Francisco, California

  • Chase Medical Research LLC - Waterbury

    Waterbury, Connecticut

  • Velocity Clinical Research - Hallandale Beach

    Hallandale, Florida

  • Indago Research and Health Center

    Hialeah, Florida

  • NeoClinical Reseaarch

    Hialeah, Florida

  • Jacksonville Center for Clinical Research

    Jacksonville, Florida

  • Health Awareness Inc

    Jupiter, Florida

  • Wr-Msra, Llc.

    Lake City, Florida

  • Sandhill Research, LLC d/b/a Accel Research Sites Network

    Lake Mary, Florida

  • Sandhill Research, LLC d/b/a Accel Research Sites

    Lake Mary, Florida

  • University Clinical Research-DeLand, LLC d/b/a Accel Research

    Lake Mary, Florida

  • South Florida Research Center, Inc

    Miami, Florida

  • Miami Clinical Research

    Miami, Florida

  • Suncoast Research Associates, LLC

    Miami, Florida

  • Clinical Site Partners, LLC dba Flourish Research

    Miami, Florida

  • Floridian Clinical Research

    Miami Lakes, Florida

  • Innovation Medical Group, LLC.

    Palmetto Bay, Florida

  • Suncoast Research Associates, LLC

    Pembroke Pines, Florida

  • St. Johns Center for Clinical Research - ERN

    Saint Augustine, Florida

  • New Tampa Health, Inc.

    Tampa, Florida

  • Synexus Clinical Research US, Inc. - The Villages

    The Villages, Florida

  • Synexus Clinical Research US, Inc. - Atlanta

    Atlanta, Georgia

Showing 40 of 103 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.